Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$49.45

1.1 (2.28%)

16:06
08/09/18
08/09
16:06
08/09/18
16:06

Puma Biotechnology reports Q2 adjusted EPS (59c), consensus ($1.26)

Reports Q2 revenue $50.8M, consensus $45.67M. "In the second quarter of 2018, we saw strong commercial progress for Puma," said Alan H. Auerbach, Chairman, Chief Executive Officer and President of Puma. "We continued to grow NERLYNX sales in the United States, with net sales of NERLYNX rising approximately 41% from the 2018 first quarter. We were also pleased that the Committee for Medicinal Products for Human Use adopted a positive opinion recommending marketing authorization for NERLYNX for the extended adjuvant treatment of adult patients with early stage hormone receptor positive HER2-overexpressed/amplified breast cancer and who are less than one year from the completion of prior adjuvant trastuzumab based therapy. The CHMP recommendation will now be reviewed by the European Commission, which has the authority to approve medicines for the European Union."

  • 09

    Aug

PBYI Puma Biotechnology
$49.45

1.1 (2.28%)

05/04/18
SBSH
05/04/18
NO CHANGE
SBSH
Buy
Puma's Nerlynx can achieve blockbuster status, says Citi
An analysis of 90 oncology drug launches indicates that products with U.S. sales of at least $200M in the first full calendar year have a greater than 50% probability of reaching $1B-plus sales, Citi analyst Yigal Nochomovitz tells investors in a research note. He believes the analysis supports his view that $1.1B of U.S. sales for Nerlynx by 2024 is an achievable goal, based on Puma Biotechnology's 2018 guidance of $175M-$200M. The analyst keeps a Buy rating on the shares.
05/10/18
SBSH
05/10/18
NO CHANGE
SBSH
Puma Biotechnology weakness a buying opportunity, says Citi
05/10/18
SBSH
05/10/18
NO CHANGE
Target $146
SBSH
Buy
Citi says Puma Biotechnology post-earnings selloff 'far overdone'
Citi analyst Yigal Nochomovitz sees several possible explanations for the post-earnings pullback in shares of Puma Biotechnology, including lower apparent demand for Nerlynx in April, the Q1 cumulative discontinuation rate having risen sequentially to 12% from 9% in the prior quarter and the fact that its third-line metastatic trial is being pushed into the second half or perhaps 2019. However, concluding that the Nerlynx launch may be stalling "seems premature," the discontinuation rate data are still "well within" his expectations and the pushback of NALA data should "only be viewed favorably" given that this is perceived by many to be a risky trial, Nochomovitz tells investors. The analyst, who recommends buying on the dip, has a Buy rating and $146 price target on Puma shares.
06/26/18
JPMS
06/26/18
NO CHANGE
Target $80
JPMS
Overweight
Positive CHMP vote a 'clear upside surprise' for Puma, says JPMorgan
JPMorgan analyst Cory Kasimov called the positive CHMP trend vote recommending approval for neratinib a "clear upside surprise" and "much needed piece of very good news" for Puma Biotechnology. Kasimov notes he had fully removed EU sales following the previous initial negative vote in January so a formal positive opinion next month and sales in early 2019 would represent "pure upside" to his estimates. The news should also likely add to neratinib's strategic value, said Kasimov, who keeps an Overweight rating and $80 price target on Puma shares.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

13:30
11/21/18
11/21
13:30
11/21/18
13:30
Options
Vix calls lead puts 4:1 as the index drops 9% »

Vix calls lead puts 4:1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKRX

Akorn

$6.95

0.18 (2.66%)

13:25
11/21/18
11/21
13:25
11/21/18
13:25
Options
Akorn call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

OMED

OncoMed

$1.37

(0.00%)

13:22
11/21/18
11/21
13:22
11/21/18
13:22
Hot Stocks
OncoMed awarded European patent for method for making heteromultimeric molecules 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$10.12

-3.05 (-23.16%)

, RDY

Dr. Reddy's

$36.37

-0.11 (-0.30%)

13:17
11/21/18
11/21
13:17
11/21/18
13:17
Hot Stocks
Aquestive under pressure after generic Suboxone patent decision »

Shares of Aquestive…

AQST

Aquestive Therapeutics

$10.12

-3.05 (-23.16%)

RDY

Dr. Reddy's

$36.37

-0.11 (-0.30%)

MYL

Mylan

$33.29

-0.65 (-1.92%)

ENDP

Endo

$12.39

-0.14 (-1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 02

    Dec

  • 04

    Dec

  • 19

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/21/18
11/21
13:17
11/21/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/21/18
11/21
13:16
11/21/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$12.60

0.3 (2.44%)

, T

AT&T

$30.01

0.6 (2.04%)

13:15
11/21/18
11/21
13:15
11/21/18
13:15
Hot Stocks
GameStop jumps over 10% after agreeing to sell Spring Mobile unit »

Shares of GameStop (GME)…

GME

GameStop

$12.60

0.3 (2.44%)

T

AT&T

$30.01

0.6 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 03

    Dec

MDT

Medtronic

$93.03

0.72 (0.78%)

13:11
11/21/18
11/21
13:11
11/21/18
13:11
Hot Stocks
Medtronic to acquire Nutrino Health, terms not disclosed »

Medtronic announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

13:10
11/21/18
11/21
13:10
11/21/18
13:10
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

13:07
11/21/18
11/21
13:07
11/21/18
13:07
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/21…

GME

GameStop

$12.60

0.3 (2.44%)

13:06
11/21/18
11/21
13:06
11/21/18
13:06
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BHGE

Baker Hughes

$22.68

0.27 (1.20%)

13:04
11/21/18
11/21
13:04
11/21/18
13:04
Hot Stocks
Baker Hughes reports U.S. rig count down 3 to 1,079 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

VLKAY

Volkswagen

$0.00

(0.00%)

, AVGO

Broadcom

$232.01

4.32 (1.90%)

13:04
11/21/18
11/21
13:04
11/21/18
13:04
Periodicals
Broadcom agrees to settle patent lawsuit against Volkswagen, Reuters says »

Volkswagen (VLKAY) has…

VLKAY

Volkswagen

$0.00

(0.00%)

AVGO

Broadcom

$232.01

4.32 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ESV

Ensco

$6.62

0.43 (6.95%)

13:00
11/21/18
11/21
13:00
11/21/18
13:00
Options
Aggressive call buying in Ensco as shares gain 6.3% »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELLI

Ellie Mae

$65.08

1.4 (2.20%)

12:54
11/21/18
11/21
12:54
11/21/18
12:54
Hot Stocks
Breaking Hot Stocks news story on Ellie Mae »

HMI Capital reports 5.67%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GME

GameStop

$12.60

0.3 (2.44%)

12:50
11/21/18
11/21
12:50
11/21/18
12:50
Hot Stocks
GameStop says board still reviewing strategic, financial alternatives »

"This transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

GME

GameStop

$12.60

0.3 (2.44%)

12:49
11/21/18
11/21
12:49
11/21/18
12:49
Hot Stocks
GameStop to sell Spring Mobile unit to Prime Communications for $700M »

GameStop (GME) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

12:45
11/21/18
11/21
12:45
11/21/18
12:45
General news
Breaking General news story  »

Week of 11/21…

GME

GameStop

$12.60

0.3 (2.44%)

12:44
11/21/18
11/21
12:44
11/21/18
12:44
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OMC

Omnicom

$76.77

1.06 (1.40%)

, WPP

WPP

$54.99

1.4 (2.61%)

12:42
11/21/18
11/21
12:42
11/21/18
12:42
Hot Stocks
Omnicom rises after winning $4B U.S. Army ad account »

Shares of Omnicom (OMC)…

OMC

Omnicom

$76.77

1.06 (1.40%)

WPP

WPP

$54.99

1.4 (2.61%)

F

Ford

$9.16

0.1 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

RHT

Red Hat

$173.28

-0.22 (-0.13%)

, IBM

IBM

$118.90

1.73 (1.48%)

12:41
11/21/18
11/21
12:41
11/21/18
12:41
Periodicals
EC review of Red Hat-IBM deal to 'zoom in' on middleware, Dealreporter says »

The European Commission…

RHT

Red Hat

$173.28

-0.22 (-0.13%)

IBM

IBM

$118.90

1.73 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

AAL

American Airlines

$36.91

1.31 (3.68%)

12:36
11/21/18
11/21
12:36
11/21/18
12:36
Periodicals
American Airlines glitch briefly hampers travelers, USA Today reports »

A computer glitch in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$48.54

0.22 (0.46%)

, FOXA

21st Century Fox

$48.84

0.25 (0.51%)

12:25
11/21/18
11/21
12:25
11/21/18
12:25
OnTheFly
Box Office Battle: 'Wreck-It Ralph' seen knocking out 'Beasts,' 'Creed' »

DISNEY EXPECTED TO WIN…

FOX

21st Century Fox

$48.54

0.22 (0.46%)

FOXA

21st Century Fox

$48.84

0.25 (0.51%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$37.34

0.59 (1.61%)

T

AT&T

$29.95

0.54 (1.84%)

DIS

Disney

$113.45

1.67 (1.49%)

VIA

Viacom

$35.28

1.06 (3.10%)

VIAB

Viacom

$31.82

1 (3.24%)

SNE

Sony

$50.75

1.21 (2.44%)

LGF.A

Lionsgate

$19.08

0.77 (4.21%)

LGF.B

Lionsgate

$17.64

0.78 (4.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 29

    Nov

  • 03

    Dec

  • 04

    Dec

AG

First Majestic

$5.52

0.28 (5.34%)

12:25
11/21/18
11/21
12:25
11/21/18
12:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/21/18
11/21
12:17
11/21/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.